Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
May 11, 2023
Tickers
ATAI
CMPS
Tags
Small Cap
Psychedelics
Market News
From
Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
May 10, 2023
Tickers
HUGE
Tags
Psychedelics
Next/Generation Psychedelics
News
From
Benzinga
Stress-Related Mood Disorders And Alzheimer's: Can This Patented Ketamine Drug Help?
May 10, 2023
Tickers
SILO
Tags
Psychedelics
Ketamine Treatment
Cannabis
From
Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
Tags
Markets
News
CYBN
From
Benzinga
Legal Magic Mushroom Therapy Now Available In Oregon, But Are Prices Too Steep?
May 09, 2023
Tags
Psychedelic/Assisted Therapies
Benzinga
Market News
From
Benzinga
Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist
May 08, 2023
Tags
Psychedelic/Assisted Therapies
Benzinga
Market News
From
Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
May 08, 2023
Tickers
CMND
CMPS
HUGE
IWINF
Tags
Psychedelics
CMND
IWINF
From
Benzinga
Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings
May 07, 2023
Tickers
COPHF
Tags
Psychedelics
News
Halucenex Life Sciences
From
Benzinga
Oregon Certifies First Psychedelics-Assisted Therapy Center In The Nation
May 05, 2023
Tags
Psychedelics
News
Benzinga
From
Benzinga
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
May 05, 2023
Tickers
MNMD
Tags
News
Earnings
Psychedelics
From
Benzinga
NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs
May 05, 2023
Tags
Psychedelic/Assisted Therapies
Benzinga
Market News
From
Benzinga
Washington State County Decriminalizes Psychedelics, Gov. Calls For Special Session On Drug Policy
May 04, 2023
Tags
Entheogenic Plants
Psychedelics Reform
News
From
Benzinga
International IP Claims On Novel Psychedelic Fungi Biomass Manufacturing Gets Prelim Acceptance
May 03, 2023
Tags
Psychedelics
Albert Labs
News
From
Benzinga
Colorado's Rapidly-Progressing Measure For Legal Psychedelics Regulation Heads To Gov.'s Desk
May 03, 2023
Tags
Government
Psychedelics regulation
Psychedelics
From
Benzinga
Next-Gen Israeli Psychedelics Company Gears Up For Trial Targeting Alcohol Addiction
May 03, 2023
Tickers
CMND
Tags
News
Markets
psychedelic compound MEAI
From
Benzinga
Psychedelics Reform Update: Arizona's MDMA Gets Gov's Signature, California, Minnesota & Missouri's Progress
May 02, 2023
Tags
Benzinga
Psychedelic/Assisted Therapies
Cannabis
From
Benzinga
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations
May 02, 2023
Tickers
CMPS
JNJ
Tags
CMPS
News
MAPS PBC
From
Benzinga
EXCLUSIVE: Ibogaine Therapy Co. Bienstar On Successful Addiction Treatment, Global Market & Future Prospects
April 27, 2023
Tags
Bienstar Wellness Corp
Marco Algorta
Management
From
Benzinga
Colorado Takes Another Step In Psychedelics Regulation As Amended Bill Receives Approval
April 26, 2023
Tags
Psychedelics Colorado
Government
General
From
Benzinga
Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued
April 26, 2023
Tags
Benzinga
Psychedelic/Assisted Therapies
Cannabis
From
Benzinga
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection
April 26, 2023
Tickers
MSSTF
Tags
Guidance
Top Stories
Markets
From
Benzinga
Reunion Neuroscience Enters Compliance Period, Struggles To Remain NASDAQ Listed
April 25, 2023
Tickers
REUN
Tags
REUN
Psychedelics
NASDAQ
From
Benzinga
New Set Of MDMA Analogs To Hit The Clinic: These Are The Latest Positive Findings
April 25, 2023
Tickers
MYCOF
Tags
MYCOF
Psychedelics
Benzinga
From
Benzinga
Can AI Foster Research And Psychedelics Therapy Without Replacing Human Connection?
April 24, 2023
Tags
Sam Altman
Markets
Opinion
From
Benzinga
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
Tickers
AWKNF
CMND
DRUG
HUGE
Tags
LOBEF
PSIL
Market News
From
Benzinga
Psychedelics Reform Update: NC's $5M Grant, WA's Pilot Program, Plus Rescheduling Proposals
April 21, 2023
Tags
Psychedelics
FDA
Benzinga
From
Benzinga
Psychedelics Therapy For Teens, Elders, And Borderline Disorder Patients: Here Are The Latest Findings
April 21, 2023
Tags
Benzinga
Psychedelic/Assisted Therapies
Cannabis
From
Benzinga
Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off
April 20, 2023
Tickers
CMND
Tags
Penny Stocks
Psychedelic/Assisted Therapies
Benzinga
From
Benzinga
Psyched Business: Lobe Buys Rare Disease Treatment, Plus Healing CREI And Heally Team Up
April 20, 2023
Tickers
LOBEF
Tags
Sickle Cell Disease
News
Rare Diseases
From
Benzinga
Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds
April 20, 2023
Tickers
DRUG
SILO
Tags
News
anxiety disorders
Management
From
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.